- Location
Neuralstem
"-
Neuralstem Has Obtained Notice of Allowance for a Patent
Apr 8, 2013Neuralstem has obtained notice of allowance for a patent that covers various methods to use expanded spinal cord stem cells such as NSI-566 to treat amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). The company completed Phase ...
-
Neuralstem Granted License to Use Its Spinal Cord Delivery Platform and Q Therapeutics
Dec 18, 2012Neuralstem has granted license to use its spinal cord delivery platform and floating cannula to Q Therapeutics. The delivery platform and floating cannula are designed for delivering therapeutic agents to the spinal cord of patients with ...
Tags: Neuralstem, license, delivery platform, floating cannula, Q Therapeutics
